Iliadis A - Search Results

1

[Pharmacokinetics in phase IV studies for the preview of a therapeutic protocol].

Favre R, Charbit M, Rinaldi Y, Iliadis A, Cano JP, Carcassonne Y. Favre R, et al. Among authors: iliadis a. Bull Cancer. 1988;75(6):541-50. Bull Cancer. 1988. PMID: 3416086 French.

2

Dynamical dosage regimen calculations in linear pharmacokinetics.

Iliadis A, Bruno R, Cano JP. Iliadis A, et al. Comput Biomed Res. 1988 Jun;21(3):203-20. doi: 10.1016/0010-4809(88)90028-6. Comput Biomed Res. 1988. PMID: 3383552

3

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after methotrexate infusions.

Bore P, Iliadis A, Catalin J, Just S, Cano JP. Bore P, et al. Among authors: iliadis a. Cancer Drug Deliv. 1987;4(3):177-83. doi: 10.1089/cdd.1987.4.177. Cancer Drug Deliv. 1987. PMID: 3502454

4

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

Rahmani R, Bruno R, Iliadis A, Favre R, Just S, Barbet J, Cano JP. Rahmani R, et al. Among authors: iliadis a. Cancer Res. 1987 Nov 1;47(21):5796-9. Cancer Res. 1987. PMID: 3664483

5

Assay of methotrexate and 7-hydroxymethotrexate by gradient-elution high-performance liquid chromatography and its application in a high-dose pharmacokinetic study.

Fabre G, Cano JP, Iliadis A, Carcassonne Y, Favre R, Gilli R, Catalin J. Fabre G, et al. Among authors: iliadis a. J Pharm Biomed Anal. 1984;2(1):61-72. doi: 10.1016/0731-7085(84)80090-4. J Pharm Biomed Anal. 1984. PMID: 16867766

6

Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.

Garraffo R, Iliadis A, Cano JP, Dellamonica P, Lapalus P. Garraffo R, et al. Among authors: iliadis a. J Pharm Sci. 1989 Sep;78(9):753-7. doi: 10.1002/jps.2600780911. J Pharm Sci. 1989. PMID: 2585270

7

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.

Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R. Dupuis C, et al. Among authors: iliadis a. Anticancer Drugs. 2008 Mar;19(3):267-73. doi: 10.1097/cad.0b013e3282f21376. Anticancer Drugs. 2008. PMID: 18510172

8

Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocol.

Cano JP, Bruno R, Lena N, Favre R, Iliadis A, Imbert AM. Cano JP, et al. Among authors: iliadis a. Cancer Drug Deliv. 1985 Fall;2(4):271-6. doi: 10.1089/cdd.1985.2.271. Cancer Drug Deliv. 1985. PMID: 3864520

9

Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearance.

Bruno R, Iliadis A, Favre R, Lena N, Imbert AM, Cano JP. Bruno R, et al. Among authors: iliadis a. Cancer Drug Deliv. 1985 Fall;2(4):277-83. doi: 10.1089/cdd.1985.2.277. Cancer Drug Deliv. 1985. PMID: 4063950

10

Time dependency of adriamycin.

Gil P, Favre R, Durand A, Iliadis A, Cano JP, Carcassone Y. Gil P, et al. Among authors: iliadis a. Bull Cancer. 1982;69(1):58. Bull Cancer. 1982. PMID: 7074234 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters